The safety of amodiaquine use in pregnant women - sprookjes - yvandenbroek - TriplyDB

The safety of amodiaquine use in pregnant women

The safety of amodiaquine use in pregnant women

http://www.wikidata.org/entity/Q28255205

about

Antimalarial drug combinations for treating uncomplicated malaria in pregnancy High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581 Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania New medicines for tropical diseases in pregnancy: catch-22.Treating severe malaria in pregnancy: a review of the evidence Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria.Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy.Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy.Pharmacokinetics of antimalarials in pregnancy: a systematic review.Treatment regimens for pregnant women with falciparum malaria.

P2860

Q24188103-4F782270-4291-43D6-8BD2-8F8E8CE8D425 Q28474860-7C312ABF-C5A6-4A1F-87F7-1144DC9D3571 Q28475232-9A080D5C-F1B2-436A-9B84-B2D133368362 Q33344906-0CA543CC-FA1E-49E4-A8B0-020EA34D9AFD Q34456393-421C72B0-1D06-4DB6-B8FA-1364652CE13D Q35191473-2E607901-D15D-4F64-943A-F78812669903 Q36364248-B40A684E-D533-45C6-B385-EEDB4413F493 Q37735182-6A2CB0D3-3764-43C5-856B-883A2B38D811 Q37942645-C16A7AA2-51F9-4B12-8ED2-6F75AFF8BC40 Q38870452-1C87D43A-0B85-4293-ACC3-52AEC9DABFE6

P2860

The safety of amodiaquine use in pregnant women

http://www.wikidata.org/entity/Q28255205

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

The safety of amodiaquine use in pregnant women

@ast

The safety of amodiaquine use in pregnant women

@en

The safety of amodiaquine use in pregnant women

@nl

type

label

The safety of amodiaquine use in pregnant women

@ast

The safety of amodiaquine use in pregnant women

@en

The safety of amodiaquine use in pregnant women

@nl

prefLabel

The safety of amodiaquine use in pregnant women

@ast

The safety of amodiaquine use in pregnant women

@en

The safety of amodiaquine use in pregnant women

@nl

P1433

Q28255205-60A948B2-BE61-48EE-B273-AC9CE0E91485

P1476

Q28255205-08695E67-7533-44D4-9C0D-B957FA4F766C

P2093

Q28255205-99BC191C-4E1D-49F5-8D53-0275BB09301C

P2860

Q28255205-0950DFCD-CF45-49B4-815A-8ED1936174FE

Q28255205-0D6E12C3-8AEC-4931-BE9F-E9C2A70E9A93

Q28255205-198C36AE-0A43-414C-A7D0-8EC6C408A94B

Q28255205-2293CE28-4224-4E5C-847A-62886023C299

Q28255205-3D3AAF4A-8200-4397-8922-2ED2C8B80E63

Q28255205-44C42F80-07E7-42DA-ACE0-EB4F82193554

Q28255205-496EB84D-6602-4C45-AC83-A2B7B9D72B38

Q28255205-56ADE022-7110-48B2-8E3D-6A7107831507

Q28255205-5B2F6C4D-7317-44BB-8287-F7802C63C3AA

Q28255205-5E6E41A8-7137-45A6-A57A-ECB304391FBA

P304

Q28255205-CB537800-E250-4F53-906D-5D0AC4963D2B

P31

Q28255205-66B1F40A-2A8A-49B3-BC83-3B3EFD2681A6

P356

Q28255205-697DF258-D82A-41D1-B84D-2147A148B114

P407

Q28255205-0B8B8598-3EAA-4E44-BAB9-F0C2D84D4B75

P433

Q28255205-804EDE84-E9AD-4933-ACF3-4E6B41CB525B

P478

Q28255205-2031871A-5F06-4104-99C8-41C50910B7C0

P50

Q28255205-6269B787-1D6D-4C61-B63A-EDC5C91E1857

Q28255205-94001854-C75E-4C1E-97EF-7AB3789D5CE6

P577

Q28255205-A483BA2A-AFDF-48FD-9343-9018D6E3AC07

P698

Q28255205-9824EEDB-A312-46F4-92C4-9D4DF7BDE279

P921

Q28255205-1491C45B-AF11-4241-9E8F-35398AA7903B

Q28255205-8225BDBB-45AD-47A0-8654-EF33D46AD202

P356

14740338.6.6.631

P1433

Expert Opinion on Drug Safety

P1476

The safety of amodiaquine use in pregnant women

@en

P2093

Harry K Tagbor

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan

Therapeutic efficacy test in malaria falciparum in Antioquia, Colombia.

The disposition of amodiaquine in Zambians and Nigerians with malaria.

Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial.

Pharmacovigilance of antimalarial treatment in Africa: is it possible?

Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa.

Antimalarial compounds: from bench to bedside.

Can amodiaquine be used safely during pregnancy?

Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré

Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar.

P304

631-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.6.6.631

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Brian Greenwood

Daniel Chandramohan

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17967151

http://www.w3.org/2001/XMLSchema#string

P921